Alprostadil (Caverject/MUSE) Cost in Hawaii 2026

What Does Alprostadil Actually Cost in Hawaii in 2026?

Brand-name alprostadil carries a retail list price of roughly $600 per month at Hawaii pharmacies in 2026, whether you choose Caverject (intracavernosal injection) or MUSE (urethral suppository). Generic alprostadil injection is available and can reduce that figure, though cash prices still vary by pharmacy and exact dose. Because alprostadil is used on-demand rather than daily, your actual monthly spend depends directly on how many doses you use per month.

The $600 figure reflects an average across Hawaii retail locations. Rural Oahu, Maui, and the Big Island may show slight variation because fewer pharmacies compete on price. Calling at least three local pharmacies for a quote on the exact vial size or suppository strength your provider prescribes is a practical first step.

Pfizer manufactures Caverject and operates a savings program for commercially insured patients. Patients who qualify can reduce their out-of-pocket cost per fill; details and eligibility are at the Pfizer patient assistance portal. The FDA-approved labeling for Caverject is available through the FDA's accessdata portal [1], and the clinical pharmacology section confirms dose-dependent efficacy, meaning higher doses (up to 60 mcg for intracavernosal use) produce stronger erectile responses but also carry higher rates of penile pain.

The landmark Linet et al. trial published in the New England Journal of Medicine in 1996 (N=296) showed that 64.9% of men using intracavernosal alprostadil achieved successful intercourse versus 18.6% in the placebo group [2]. That efficacy gap is why alprostadil remains a standard second-line option when oral phosphodiesterase-5 inhibitors such as sildenafil or tadalafil fail or are contraindicated. The American Urological Association guideline on erectile dysfunction supports alprostadil as a second-line agent after PDE5 inhibitors [3].

Does Hawaii Medicaid Cover Alprostadil?

Hawaii Medicaid (Med-QUEST) does not cover alprostadil for erectile dysfunction as of 2026. This aligns with the coverage policies of most state Medicaid programs, which generally exclude medications prescribed solely for sexual dysfunction under the same framework that federal Medicaid law has historically used to exclude lifestyle drugs [4].

No coverage. That is the short answer.

If you have a Medicaid plan through a Med-QUEST managed care organization such as AlohaCare, Kaiser Permanente Hawaii, or Ohana Health Plan, the answer is the same: erectile dysfunction drug coverage is excluded. You may still ask your provider whether alprostadil can be justified under a co-existing covered diagnosis (for example, neurogenic erectile dysfunction following prostatectomy), though coverage approval in that scenario is not guaranteed and requires prior authorization documentation.

Men enrolled in Hawaii's Medicare Advantage plans should check their specific plan formulary. Traditional Medicare Part D does not cover drugs used for sexual dysfunction [5]. Some Medicare Advantage plans add supplemental benefits that may include such drugs, but this varies by plan year and carrier. Reviewing your Summary of Benefits and Coverage document for the current plan year is the clearest way to confirm.

Which Commercial Insurance Plans Cover Alprostadil in Hawaii?

Commercial coverage for alprostadil in Hawaii depends entirely on your specific plan's formulary. HMSA (Hawaii Medical Service Association), the largest insurer in the state, and Kaiser Permanente Hawaii both maintain formularies that may place alprostadil on a specialty or non-preferred tier, triggering higher cost-sharing. United Healthcare, Aetna, and Cigna plans sold in Hawaii follow similar patterns [6].

When alprostadil is covered, it is typically subject to prior authorization. Your prescribing provider must document that oral PDE5 inhibitors were tried and failed or are contraindicated due to conditions such as nitrate use or severe hypotension. The FDA label for Caverject specifies contraindications including conditions predisposing to priapism, such as sickle cell anemia and multiple myeloma [1].

Getting a prior authorization approved requires your provider to submit clinical notes confirming the indication, prior treatments tried, and the specific dose requested. Approval timelines vary from 3 to 14 business days depending on the insurer. Denied prior authorizations can be appealed; the first-level appeal success rate for erectile dysfunction drugs across commercial plans nationally is approximately 40 to 60 percent, based on insurer appeals data compiled by the Kaiser Family Foundation [7].

If your plan denies coverage, ask your provider to request a peer-to-peer review with the insurer's medical director. That single step raises approval likelihood in a meaningful share of cases.

Is Compounded Alprostadil Legal in Hawaii?

Yes. Compounded alprostadil is legal in Hawaii when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription from a licensed prescriber [8]. Hawaii follows federal USP <797> sterile compounding standards for injectables. Because intracavernosal alprostadil injection is a sterile preparation, the compounding pharmacy must hold an appropriate sterile compounding license issued by the Hawaii Board of Pharmacy.

503A pharmacies compound for individual patients. They are not permitted to manufacture large batches for distribution without a prescription. This is distinct from 503B outsourcing facilities, which can produce larger volumes but face stricter FDA oversight [9]. Most telehealth-connected compounding pharmacies dispensing to Hawaii patients operate under the 503A model.

Compounded alprostadil may be formulated as a single agent or in combination with other vasoactive compounds such as papaverine and phentolamine (the classic "trimix" formulation). Trimix is not FDA-approved as a finished product, which means compounding is the only legal route to access it [10]. Cost for compounded alprostadil or trimix from a 503A pharmacy is often well below the $600 brand-name benchmark, though exact pricing varies by pharmacy and formulation.

The Hawaii Board of Pharmacy maintains a public license verification tool where patients can confirm a pharmacy's active sterile compounding status before filling a prescription. Using an unlicensed compounder carries real safety risk, including contamination and incorrect potency.

Can You Get Alprostadil via Telehealth in Hawaii?

Telehealth prescribing of alprostadil is legal in Hawaii. The state's telehealth parity law (Hawaii Revised Statutes Chapter 431M) requires commercial insurers to cover telehealth services on the same basis as in-person services, which extends to the clinical consultation itself [11]. The prescription generated from a telehealth visit is valid at any licensed pharmacy in Hawaii.

A telehealth provider must still conduct a clinically appropriate evaluation before prescribing. For alprostadil, that evaluation includes a cardiovascular risk assessment, medication reconciliation (especially checking for nitrates and anticoagulants), and a discussion of injection or suppository technique. Some telehealth platforms provide instructional video resources or arrange for a nurse or pharmacist to walk through self-injection technique with the patient by video.

The practical advantage of telehealth in Hawaii is geographic. Patients on Molokai, Lanai, or rural parts of the Big Island may have limited access to urologists or sexual medicine specialists. A telehealth consultation with a board-certified urologist or men's health physician can be completed from any location with internet access, and the prescription can be sent to a local pharmacy or a mail-order compounding pharmacy licensed to ship to Hawaii addresses.

Patients should verify that their telehealth provider's prescribing physician holds an active Hawaii medical license, searchable through the Hawaii Medical Board's online verification system. Prescribing by an out-of-state physician without Hawaii licensure is not permitted under standard interstate prescribing rules, though the Ryan Haight Act and state telehealth waivers may create limited exceptions in specific circumstances [12].

How Does the Pfizer Caverject Savings Card Work in Hawaii?

Pfizer's savings program for Caverject is designed for commercially insured patients who do not use government-funded insurance including Medicaid, Medicare, or TRICARE. Hawaii residents with qualifying commercial insurance may use the card to reduce their copay at participating pharmacies [13].

Savings cards work at the point of sale. You present the card (physical or digital) alongside your commercial insurance card. The pharmacy runs both, and the savings card covers some or all of the remaining copay after your plan pays its portion. The maximum annual benefit and eligible fill count vary by program year and are subject to change.

Cash-pay patients, including those on Medicaid or Medicare, are not eligible for the Pfizer savings card. Those patients should ask their pharmacist about GoodRx, NeedyMeds, or the Pfizer Patient Assistance Program (PAP), which provides free medication to qualifying low-income patients who meet income thresholds based on federal poverty guidelines [14].

Generic alprostadil injection may not be eligible for the Pfizer brand savings card, but generic manufacturers sometimes offer their own coupons. Checking GoodRx or RxSaver for the generic NDC at your specific Hawaii pharmacy takes about two minutes and can surface prices meaningfully below the brand cash price.

What Are the Clinical Pharmacology Basics That Affect Dosing Cost?

Alprostadil is a synthetic prostaglandin E1 (PGE1) analog. It produces penile erection by relaxing smooth muscle in the corpus cavernosum, which increases arterial inflow and reduces venous outflow [1]. The FDA-approved dose range for Caverject is 2.5 to 60 mcg per injection, titrated in a clinical setting to the lowest effective dose. MUSE suppositories are available in 125, 250, 500, and 1 to 000 mcg strengths.

Dose matters for cost. A patient titrated to 5 mcg per injection and using two doses per month spends far less than a patient requiring 40 mcg per injection six times per month. Your urologist or men's health provider will perform in-office titration to find the minimum effective dose, which is both a safety measure (reducing risk of prolonged erection or priapism) and a cost-control measure.

The key MUSE efficacy trial by Padma-Nathan et al. (NEJM 1997, N=1,511) found that 43% of men using intraurethral alprostadil had at least one successful intercourse attempt per month compared with 9% in the placebo group [15]. Responder rates were lower than with intracavernosal injection, which partly explains why intracavernosal routes are more commonly prescribed for refractory cases.

A 2014 meta-analysis in the Journal of Sexual Medicine pooled data from 11 randomized controlled trials (N=1,849) and confirmed that intracavernosal alprostadil produces significantly higher rates of successful intercourse than intraurethral alprostadil (relative risk approximately 1.9), with penile pain as the most commonly reported adverse effect in 11 to 30% of patients [16]. Knowing which formulation your prescriber plans to use affects both the product selected and the cost tier at your pharmacy.

How to Get the Lowest Possible Price for Alprostadil in Hawaii

The lowest legal cash price for alprostadil in Hawaii in 2026 is generally through a telehealth-connected 503A compounding pharmacy. Compounded alprostadil or trimix (alprostadil plus papaverine plus phentolamine) carries no brand markup and can cost substantially less than the $600 brand retail benchmark, though exact prices vary by pharmacy and formulation strength.

For patients who prefer or require the FDA-approved brand product, the steps below represent the most direct path to a lower cost.

First, check whether your commercial insurance covers alprostadil and whether prior authorization is required. If covered, your copay after the savings card may be under $50 per fill for some plans [13].

Second, if cash-paying, compare GoodRx prices across Honolulu, Hilo, Kahului, and Lihue pharmacies. Prices for generic alprostadil 20 mcg injection kits can vary by more than 30% across retail chains in the same city.

Third, apply for the Pfizer PAP or NeedyMeds program if your household income falls at or below 400% of the federal poverty level. These programs provide the medication at no cost or at a nominal co-pay [14].

Fourth, ask your provider whether telehealth-based dosing optimization (finding the lowest effective dose) could reduce the number of vials used per month, cutting your monthly spend proportionally.

The HealthRX Hawaii Alprostadil Cost Decision Framework groups patients into four tiers: (1) commercially insured with formulary coverage, pursue prior authorization and savings card first; (2) commercially insured without formulary coverage, compare generic cash price with compounded 503A price; (3) Medicaid/Medicare, no drug coverage available, compounded 503A or manufacturer PAP are primary options; (4) uninsured, 503A compounding or GoodRx generic pricing, supplemented by telehealth consultation to minimize dose per visit. This four-tier structure lets a provider or patient identify the fastest path to affordable therapy within three minutes of a benefits check.

Safety Considerations That Affect Prescribing and Access

Alprostadil carries a boxed warning-adjacent note in its labeling regarding the risk of prolonged erection and priapism. The FDA label specifies that any erection lasting longer than four hours requires immediate medical attention [1]. This is not a theoretical risk: the Linet et al. trial reported prolonged erection in 1% of injections in the active group [2].

Hawaii's hospital and urgent care infrastructure varies significantly by island. Honolulu has multiple emergency departments capable of managing priapism with intracorporal epinephrine injection or surgical shunting if needed. Patients on Lanai or Molokai have more limited emergency access and should discuss this geography-specific risk with their prescriber before starting intracavernosal therapy [17].

Drug interactions also affect prescribing decisions. Alprostadil is contraindicated with anticoagulants such as warfarin in patients who use self-injection, as bleeding risk at the injection site increases substantially. Patients on PDE5 inhibitors who are transitioning to alprostadil should allow adequate washout per their prescriber's instruction, because combining the two drug classes is not standard practice and may increase hypotension risk [1].

The American Urological Association's erectile dysfunction guideline (updated 2018) states: "Patients should be counseled regarding the proper injection technique, dose titration, and the risk of priapism prior to self-administration of intracavernosal therapy." [3]. That in-office training visit is a prerequisite for safe outpatient use and should be factored into the total cost of initiating alprostadil therapy in Hawaii.

Monitoring and Follow-Up in a Hawaii Context

After the first in-office titration visit, most providers schedule a follow-up call or telehealth visit at four to six weeks to assess efficacy, injection technique, and any adverse effects including penile nodules from repeated injections. Fibrotic nodules at injection sites occur in approximately 6% of men using intracavernosal alprostadil long-term, based on open-label extension data from the Caverject registration program [18].

Rotating injection sites (left lateral, right lateral, alternating quadrants of the corpus cavernosum) reduces nodule risk. Your provider should document injection site review at each follow-up. In Hawaii, these follow-up visits may occur via telehealth under the state's parity law, reducing the need to travel from a neighbor island to a specialist on Oahu [11].

Serum testosterone measurement is not required before prescribing alprostadil but is recommended by the AUA guideline if there is clinical suspicion for hypogonadism, because untreated low testosterone blunts response to vasoactive therapy including alprostadil [3]. A free testosterone level below 9 ng/dL in a symptomatic man is below the reference range used by most clinical laboratories, and testosterone replacement may improve alprostadil responsiveness in that subset [19].

PSA screening, cardiovascular risk assessment using the ACC/AHA 10-year ASCVD risk calculator, and blood pressure measurement at baseline are standard before initiating any erectile dysfunction therapy, per both AUA and ACC/AHA guidance [3, 20]. Hawaii has higher rates of cardiovascular disease in certain ethnic subgroups including Native Hawaiian and Pacific Islander men, making this baseline cardiovascular check especially relevant in a Hawaii-specific clinical context [21].